Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lessons learned from recent cardiovascular clinical trials: Part I.

Literature DB >> 12163438

Lessons learned from recent cardiovascular clinical trials: Part I.

David L DeMets¹, Robert M Califf.

Abstract

Mesh：

Year: 2002 PMID： 12163438 DOI： 10.1161/01.cir.0000023219.51483.66

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

Keyword Cloud
Cited

× No keyword cloud information.

22 in total

1. Potential use of coronary artery calcium progression to guide the management of patients at risk for coronary artery disease events.

Authors: John W McEvoy; Michael J Blaha; Khurram Nasir; Roger S Blumenthal; Steven R Jones
Journal: Curr Treat Options Cardiovasc Med Date: 2012-02

Review 2. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.

Authors: Ignacio Ferreira-González; Jason W Busse; Diane Heels-Ansdell; Victor M Montori; Elie A Akl; Dianne M Bryant; Pablo Alonso-Coello; Jordi Alonso; Andrew Worster; Suneel Upadhye; Roman Jaeschke; Holger J Schünemann; Gaietà Permanyer-Miralda; Valeria Pacheco-Huergo; Antònia Domingo-Salvany; Ping Wu; Edward J Mills; Gordon H Guyatt
Journal: BMJ Date: 2007-04-02

Review 3. Advancing outcome measures for the new era of drug development in cystic fibrosis.

Authors: Nicole Mayer-Hamblett; Bonnie W Ramsey; Richard A Kronmal
Journal: Proc Am Thorac Soc Date: 2007-08-01

4. Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH Health Care Systems Collaboratory.

Authors: Rachel L Richesson; W Ed Hammond; Meredith Nahm; Douglas Wixted; Gregory E Simon; Jennifer G Robinson; Alan E Bauck; Denise Cifelli; Michelle M Smerek; John Dickerson; Reesa L Laws; Rosemary A Madigan; Shelley A Rusincovitch; Cynthia Kluchar; Robert M Califf
Journal: J Am Med Inform Assoc Date: 2013-08-16 Impact factor: 4.497

5. A Combined Measure of Cognition and Function for Clinical Trials: The Integrated Alzheimer's Disease Rating Scale (iADRS).

Authors: A M Wessels; E R Siemers; P Yu; S W Andersen; K C Holdridge; J R Sims; K Sundell; Y Stern; D M Rentz; B Dubois; R W Jones; J Cummings; P S Aisen
Journal: J Prev Alzheimers Dis Date: 2015-12-01

6. Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Myocardial imaging should not exclude patients with ischemic heart failure from coronary revascularization.

Authors: Eric J Velazquez
Journal: Circ Cardiovasc Imaging Date: 2012-03 Impact factor: 7.792

Lessons learned from recent cardiovascular clinical trials: Part I.

1. Potential use of coronary artery calcium progression to guide the management of patients at risk for coronary artery disease events.

Review 2. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.

Review 3. Advancing outcome measures for the new era of drug development in cystic fibrosis.

4. Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH Health Care Systems Collaboratory.

5. A Combined Measure of Cognition and Function for Clinical Trials: The Integrated Alzheimer's Disease Rating Scale (iADRS).

6. Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Myocardial imaging should not exclude patients with ischemic heart failure from coronary revascularization.

7. Exploring the ethical and regulatory issues in pragmatic clinical trials.

8. Testing for heterogeneity among the components of a binary composite outcome in a clinical trial.

Review 9. Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis.

10. The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned.